La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (Istex)

Index « Titre (en) » - entrée « dopa »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
donors < dopa < dopamine  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]
Ident.Authors (with country if any)Title
000584 (2010) Szu-Chia Lai ; Shih-Ming Jung [Taïwan] ; Padraic Grattan-Smith [Australie] ; Ella Sugo [Australie] ; Yen-Wen Lin [Taïwan] ; Rou-Shayn Chen ; Chiung-Chu Chen ; Yah-Huei Wu-Chou [Taïwan] ; Anthony E. Lang [Canada] ; Chin-Song Lu [République populaire de Chine]Neuronal intranuclear inclusion disease: Two cases of dopa‐responsive juvenile parkinsonism with drug‐induced dyskinesia
000610 (2010) Bernard Ng [Canada] ; Samantha Palmer [Canada] ; Rafeef Abugharbieh [Canada] ; Martin J. Mckeown [Canada]Focusing effects of L‐dopa in Parkinson's disease
000884 (2008) Joohyung Lee [Canada, Australie] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Naomi Visanji [Canada] ; Jonathan M. Brotchie [Canada]Receptor‐activity modifying protein 1 expression is increased in the striatum following repeated L‐DOPA administration in a 6‐hydroxydopamine lesioned rat model of Parkinson's disease
000899 (2008) Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Fréderic Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Mehdi Dridi [Canada] ; Nancy Belanger [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L‐dopa‐induced dyskinesias in MPTP parkinsonian monkeys
000B77 (2006) Michel St-Hilaire [Canada] ; Emmanuelle Bourhis [Canada] ; Daniel Lévesque [Canada] ; Claude Rouillard [Canada]Impaired behavioural and molecular adaptations to dopamine denervation and repeated L‐DOPA treatment in Nur77‐knockout mice
000B95 (2006) Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni]Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa
000E16 (2003) Raúl De La Fuente-Fernández [Canada] ; Sarah Furtado [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]VMAT2 binding is elevated in dopa‐responsive dystonia: Visualizing empty vesicles by PET
000E74 (2003) Ronald B. Postuma [Canada, États-Unis] ; Yoshiaki Furukawa [Canada, États-Unis] ; Ekaterina Rogaeva [Canada, États-Unis] ; Peter H. St. George-Hyslop [Canada, États-Unis] ; Matt J. Farrer [Canada, États-Unis] ; Anthony E. Lang [Canada, États-Unis]Dopa‐responsive dystonia presenting with prominent isolated bilateral resting leg tremor: Evidence for a role of parkin?
000F01 (2002) Pramod K. Pal [Canada] ; Joanne Leung [États-Unis] ; Katya Hedrich [Allemagne] ; Ali Samii [Canada] ; Abraham Lieberman [États-Unis] ; Paul A. Nausieda [États-Unis] ; Donald B. Calne [Canada] ; Xandra O. Breakefield [États-Unis] ; Christine Klein [Allemagne] ; A. Jon Stoessl [Canada][18F]‐Dopa positron emission tomography imaging in early‐stage, non‐parkin juvenile parkinsonism
000F42 (2002) Yoshiaki Furukawa [Canada] ; Gregory Kapatos [États-Unis] ; John W. Haycock [États-Unis] ; Julian Worsley [Canada] ; Henry Wong [Canada] ; Stephen J. Kish [Canada] ; Torbjoern G. Nygaard [États-Unis]Brain biopterin and tyrosine hydroxylase in asymptomatic dopa‐responsive dystonia
001092 (2001) P. K. Pal [Canada] ; C. S. Lee [Canada] ; A. Samii [Canada] ; M. Schulzer [Canada] ; A. J. Stoessl [Canada] ; E. K. Mak [Canada] ; J. Wudel [Canada] ; T. Dobko [Canada] ; J. K. C. Tsui [Canada]Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET [18F]-DOPA Ki
001155 (2000) P. Foley [Allemagne] ; Y. Mizuno [Japon] ; T. Nagatsu [Japon] ; A. Sano [Japon] ; M. B. H. Youdin [Israël] ; P. Mcgeer [Canada] ; E. Mcgeer [Canada] ; P. Riederer [Allemagne]The L-DOPA story - an early Japanese contribution
001233 (2000) Yoshiaki Furukawa [Canada] ; Mark Guttman [Canada] ; Steven P. Sparagana [États-Unis] ; Joel M. Trugman [États-Unis] ; Keith Hyland [États-Unis] ; Philip Wyatt [Canada] ; Anthony E. Lang [Canada] ; Guy A. Rouleau [Canada] ; Mitsunobu Shimadzu [Japon] ; Stephen J. Kish [Canada]Dopa‐responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene
001412 (1999) E. H. Danielsen [Danemark] ; D. F. Smith [Danemark] ; A. D. Gee [Danemark] ; T. K. Venkatachalam [Danemark] ; S. B. Hansen [Danemark] ; F. Hermansen [Danemark] ; A. Gjedde [Danemark, Canada] ; P. Cumming [Danemark, Canada]Cerebral 6‐[18F]fluoro‐L‐DOPA (FDOPA) metabolism in pig studied by positron emission tomography
001577 (1997) Alex Rajput [États-Unis] ; Asha Kishore ; B. Snow ; C. F. Bolton [Canada] ; C. F. Rajput [Canada]Dopa‐responsive, nonprogressive, juvenile parkinsonism: Report of a case
001691 (1997) Chien-Tsai Lai [Canada] ; Peter H. Yu [Canada]Dopamine- and l-β-3,4-dihydroxyphenylalanine hydrochloriDe (l-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y Cells
001851 (1996) Michel P. Furukawa [Japon, Canada] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Yumiko Shimuzu [Japon] ; Tetsuzo Tagawa [Japon] ; Hideo Mori [Japon] ; Masayuki Yokochi [Japon] ; Hirotaro Narabayashi [Japon] ; Oleh Hornykiewicz [Autriche] ; Yoshikuni Mizuno [Japon] ; Stephen J. Kish [Canada]GTP‐cyclohydrolase I gene mutations in hereditary progressive and dopa‐responsive dystonia
001A29 (1995) P. J. Tuite [Canada] ; E. A. Rogaeva [Canada] ; P. H. St George-Hyslop [Canada] ; P. H. Lang [Canada]Dopa‐responsive parkinsonism phenotype of Machado‐Joseph disease: Confirmation of 14q CAG expansion
001B86 (1994) Donald B. Calne [Canada]Dopa‐responsive dystonia
001C01 (1994) Hirohide Takahashi [Canada] ; Robert A. Levine [États-Unis] ; Matthew P. Galloway [États-Unis] ; Barry J. Snow [Canada] ; Donald B. Calne [Canada] ; Donald B. Nygaard [États-Unis]Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa‐responsive dystonia
001C82 (1993) Fang Snow [Canada] ; Torbjoern G. Nygaard [États-Unis] ; Hirohide Takahashi [Canada] ; Donald B. Calne [Canada]Positron emission tomographic studies of dopa‐responsive dystonia and early‐onset idiopathic parkinsonism

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "dopa" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "dopa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    dopa
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022